Tenon Medical, Inc. TNON
Tenon Medical, Inc. (TNON) earns a Piotroski F-score of 4/9 (mixed financial health). It does not currently pay a dividend. FY2025 revenue was $3.9M at a -318.4% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -1.73 — elevated (above the −1.78 line — aggressive-accounting signals worth a closer look) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| TNON | Tenon Medical, Inc. | 4/9 | — | — | — |
| AURX | Nuo Therapeutics, Inc. | 3/9 | — | — | — |
| LUCD | Lucid Diagnostics Inc. | 3/9 | — | — | — |
| INBS | INTELLIGENT BIO SOLUTIONS INC. | 2/9 | — | — | — |
| OSRH | OSR Health, Inc. | — | 1.04 | — | — |
| USAQ | QHSLab, Inc. | 4/9 | -1.02 | — | — |
| PSTV | PLUS THERAPEUTICS, INC. | 3/9 | — | — | — |
About Tenon Medical, Inc.
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive inferior-posterior approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
FAQ
Is TNON financially healthy?
Tenon Medical, Inc.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak).
Does TNON pay a dividend?
No, Tenon Medical, Inc. does not currently pay a dividend.
How profitable is TNON?
In FY2025, Tenon Medical, Inc. had a net margin of -318.4% and a return on equity of -249.1%.
What is the analyst price target for TNON?
The average Wall-Street price target for Tenon Medical, Inc. is $2.62, about 53.5% below the recent price, from 2 analysts.
Is TNON a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Tenon Medical, Inc.: a Piotroski F-score of 4/9. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.